|
|
Volumn 47, Issue 17, 2004, Pages 4111-4112
|
|
Novel "second-generation" approaches for the control of type 2 diabetes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
BIGUANIDE DERIVATIVE;
DIPEPTIDYL PEPTIDASE;
DIPEPTIDYL PEPTIDASE IV;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
EXENDIN 4;
GLUCAGON LIKE PEPTIDE 1 RECEPTOR;
INSULIN;
LIRAGLUTIDE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR;
SERINE PROTEINASE INHIBITOR;
SULFONYLUREA DERIVATIVE;
UNCLASSIFIED DRUG;
CHRONIC DISEASE;
CLINICAL TRIAL;
DIABETES CONTROL;
DIET THERAPY;
EDEMA;
ENDOCRINE FUNCTION;
ENZYME ACTIVITY;
GLUCOSE BLOOD LEVEL;
GLUCOSE HOMEOSTASIS;
HUMAN;
HYPOGLYCEMIA;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RESEARCH;
SHORT SURVEY;
SIDE EFFECT;
WEIGHT GAIN;
ANTIGENS, CD26;
DIABETES MELLITUS, TYPE 2;
GLUCAGON;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
PEPTIDE FRAGMENTS;
PROTEASE INHIBITORS;
PROTEIN PRECURSORS;
PROTEIN-TYROSINE-PHOSPHATASE;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
TRANSCRIPTION FACTORS;
|
|
EID: 3843096263
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm030626a Document Type: Short Survey |
|
Times cited : (58)
|
|
References (0)
|
